Cheng Yi Pharmaceutical Enters the Rank of Wenzhou's "Top 100 Comprehensive Enterprises"

At the end of the year, good news comes frequently. The list of 2020 Wenzhou Top 100 Comprehensive Enterprises, Top 50 Manufacturing Enterprises, and 2020 Wenzhou Excellent Entrepreneurs jointly evaluated by Wenzhou Enterprise Federation, Wenzhou Entrepreneur Association, and Wenzhou Industrial Economy Federation (hereinafter referred to as "the three associations") was announced yesterday. Cheng Yi Pharmaceutical entered the Wenzhou Top 100 Comprehensive Enterprises and Top 50 Manufacturing Enterprises for the first time, and General Manager Zhao Chunjian was named "2020 Wenzhou Excellent Entrepreneurs". The Wenzhou Daily reported that the annual "Ranking Evaluation" of Wenzhou's Excellent Enterprises "showcases the strength of Wenzhou's large-scale enterprises, the lineup of excellent entrepreneurs, and the characteristics of Wenzhou's economy at that time.

This year is the last year of Cheng Yi Pharmaceutical's 13th Five Year Plan. Since its listing in March 2017, the company's revenue and profits have maintained an average annual growth rate of around 20-30%, with a cumulative dividend of 120 million yuan from 2017 to 2019. The company will also relocate its "three major centers" to Shanghai, achieving a significant leap from "offshore" to Shanghai, and invest 500 million yuan to build the "Cheng Yi Pharmaceutical Health Industrial Park (Phase I)", which has been listed as a provincial-level major industrial project in Zhejiang; Invest over 6 million yuan to build information systems such as ERP, OA office, and online shopping mall; More than 60 million yuan has been invested to build safety and environmental protection facilities such as natural gas boilers, new distribution and refrigeration stations, and exhaust gas upgrading systems, providing a demonstration for the green development of industrial enterprises in the province. In terms of promoting corporate culture, Cheng Yi's "good voice" has been constantly sung. Especially since this year, we have insisted on both epidemic prevention and production, and we have won two wars. On the one hand, we have comprehensively disinfection and sterilization, prevented and controlled, worked overtime to produce antiviral drugs to rescue Wuhan, donated drugs to support key epidemic areas, and achieved phased results in epidemic prevention and resistance; On the other hand, we have always adhered to the principle of production without relaxation, and made every effort to expand sales, research and development, and strengthen management. The four major economic indicators of output value, revenue, profit, and tax revenue are "commendable", making important contributions to the local economic and social development.

On December 18th, Zhao Chunjian, the general manager of the company, was also awarded the title of "Entrepreneur who made special contributions during the epidemic period in Zhejiang Province" by the "Three Meetings" of Zhejiang Province, and went to Hangzhou to attend the conference to receive the award. He stated that the company is formulating the "14th Five Year Development Plan", and in the next five years, all employees of the company will adhere to the responsibility of "Cheng Yi Pharmaceutical, benefiting the people", further promote the spirit of "diligence, thrift, rigor, innovation, and dedication", expand and strengthen the main business, and deliver a more satisfactory answer to society.